Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 06, 2016 9:26 AM ET

Biotechnology

Company Overview of Adamas Pharmaceuticals, Inc.

Key Executives for Adamas Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Gregory T. Went Ph.D.28 RelationshipsChairman and Chief Executive Officer51
William J. Dawson 6 RelationshipsChief Financial Officer60
Natalie L. McClure Ph.D.No RelationshipsSenior Vice President of Product Development62
Rajiv Patni M.D.No RelationshipsChief Medical Officer46

Adamas Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Gregory T. Went Ph.D. 28 RelationshipsAdamas Pharmaceuticals, Inc.51
David L. Mahoney 44 RelationshipsAdamas Pharmaceuticals, Inc.61
Richard H. Booth CPA, CLU, ChFC 74 Relationships1347 Capital Corp.68
Martha J. Demski 52 RelationshipsAjinomoto Althea, Inc.62
William W. Ericson J.D. 160 RelationshipsWildcat Venture Partners56
View All Board Members

Adamas Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Martha J. Demski52 Relationships3 Executives
Compensation Committee CPA, CLU, ChFCRichard H. Booth74 Relationships2 Executives
Nominating Committee David L. Mahoney44 Relationships3 Executives
Corporate Governance Committee David L. Mahoney44 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$418.3K
418.3K
333.8K
Bonus$330.5K
330.5K
219.2K
Total Short Term Compensation
Not meaningful
Total Value of Options$748.8K
748.8K
21.9M
Compensation as of Fiscal Year 2014
Adamas Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Wausau Paper Corp. Announces Management Changes
January 22, 2016 8:10 PM ET
Spectrum Brands Holdings, Inc. Appoints David M. Maura as Executive Chairman
January 21, 2016 11:30 AM ET
Peter Harf Intends to Step Down from the Board of Reckitt Benckiser Group plc
December 21, 2015 7:00 AM ET
Blue Power Group Limited Appoints Catherine K. Goodall as Director to the Board
December 05, 2015 12:00 AM ET
Procter & Gamble Co. Announces Executive Changes
November 20, 2015 11:57 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Adamas Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.